Tirzepatide 40mg Injection Pen Kit — Dual GIP / GLP-1 Receptor Agonist
Dual incretin receptor agonist formulated in a high-capacity 40mg pen kit for consistent, reproducible GIP and GLP-1 co-agonism research outcomes.
Analytical Specifications & HPLC Purity
- Batch ID: SYN-26TZ-3318B (RP-HPLC Purity: 99.48%)
- CAS / Formula: 2023788-19-2 | C225H348N48O68 (4813.45 g/mol)
- Format: 4 x 10mg | 1 click = 0.1667 mg
- Storage: 2°C – 8°C (Refrigerated) | Half-life: ~5 days (120 hours)
Kit Contents
- 1x Reusable Anodized Synedica 60-Unit Precision Pen
- 4x 10mg Sterile Pre-Filled Borosilicate Cartridges (40mg total)
- 12x Ultra-Fine 31G 4mm Siliconized Micro-Needles
- 12x Sterile 70% Isopropyl Prep Swabs
- 1x Thermal-Insulated Magnetic Presentation Case & Scratch-Off Security Seal
60-Unit Pen Titration & Click Schedule
| Weeks | Dose | Clicks | Phase |
|---|---|---|---|
| Weeks 1–4 | 2.5 mg / wk | 15 units | Baseline Incretin Priming |
| Weeks 5–8 | 5.0 mg / wk | 30 units | Standard Dual-Agonist Step |
| Weeks 9–12 | 7.5–10.0 mg / wk | 45–60 units | Enhanced Glycemic & Metabolic Phase |
| Week 13+ | 12.5–15.0 mg / wk | 75–90 units | Maximum Protocol Ceiling |